Oska Health has raised €11 million in a Seed funding round as it looks to scale its approach to supporting people living with long-term health conditions across Europe. The round was led by Capricorn Partners and SwissHealth Ventures, the investment arm of insurer CSS, with participation from Revent, Calm Storm, LBBW Venture Capital, BMH, GoHub Ventures and Aurum Impact.
The Frankfurt am Main-based healthtech company said the funding will be used to grow its team, further develop its technology and deepen its work with insurer and physician networks across the region. Oska Health operates in a part of the healthcare system that is under increasing strain, as millions of people across Europe live with multiple chronic conditions such as CKD, diabetes and hypertension.
Many patients struggle to manage these conditions between appointments, with lifestyle changes often proving difficult to maintain and medication routines breaking down. Oska Health’s model is designed to address this gap in day-to-day care, where complications can build and hospital admissions can become more likely.
Founded in 2022 by Niklas Best, Claudia Ehmke and Dr. Malte Waldeck, Oska Health was established in Frankfurt am Main and later opened an office in London. The founding team brings experience from major healthcare providers including Fresenius Medical Care and DaVita. The company is certified as a medical device, which it said positions the business to scale its model across European health systems.
Oska Health combines trained health coaches with technology-led care delivery to support patients living with more than one long-term condition. Patients receive support through video calls, chat and a dedicated therapy app. The company said its coaches help translate clinical guidance from physicians into practical daily habits, with the aim of reducing avoidable hospital admissions and improving health literacy over time.
The company’s approach is designed to sit alongside existing clinical practice rather than replace it. Physicians retain full responsibility for treatment decisions, and Oska Health said its model does not require doctors to adopt new software or change their workflows. This has helped the company secure partnerships with more than 20 statutory health insurance funds in Germany, making the service available at no cost to insured members.
For insurers, chronic conditions account for around 70% of healthcare spending in Germany, according to the company. Oska Health positions its service as a way to address daily behaviour change that is often difficult to achieve through traditional care pathways alone, with the aim of reducing complications and long-term costs.
Investors said the company is addressing a structural challenge in how long-term conditions are managed. Antoine D’Hollander, Investment Director at Capricorn Partners, said: “Oska Health is tackling a structural bottleneck in how healthcare is delivered to chronically ill patients. Over the past years, the team has built an impressive track record in partnering with health insurance funds that use Oska to organize continuous care for chronically ill patients in a medically meaningful and economically sustainable way.”
Oska Health’s leadership said the combination of human support and technology is central to its model. Niklas Best, CEO and co-founder, said: “Chronic diseases cannot be managed in isolated doctor visits – they are decided in everyday life. We combine human support with AI to close this gap. Our technology supports our coaches, reduces administrative burden, and makes high-quality chronic care scalable.”
SwissHealth Ventures also pointed to the importance of supporting patients between clinical appointments. Markus Rommel, Principal at SwissHealth Ventures, said: “For us, it is crucial that care has an impact where it has been least effective so far – between doctor visits. Oska Health has developed a compelling and scalable model to achieve exactly that.”
Existing backers highlighted Oska Health’s recent growth. German venture capital firm Revent, which has supported the company for more than two years, said it has seen strong progress since its initial investment. Otto Birnbaum, General Partner at Revent, said: “We have backed Oska Health for over two years now and are thrilled to see their growth rate of >8x, proving what a significant issue they are addressing. We are convinced that their AI-enabled coaching will help not only the millions of people suffering from chronic disease, but our strained health system as a whole.”
Oska Health said the new funding will support its next phase of expansion as it works more closely with insurers and doctors to scale its model for chronic care across Europe.
